In earlier phase two trials the company sponsored, patients taking orforglipron achieved about 14.7% weight loss, on average, almost matching Ozempic
Role of GLP-1 Receptor Agonists for Weight Loss Role of GLP-1 Receptor Agonists for Weight Loss This Harvard Medical School Continuing Education video examines these key questions: What role do GLP1 receptor agonists
Weight loss was significant in outcome trials, ranging from a 0.6 kg reduction at 12 weeks in the ELIXA trial to a 4.3 kg reduction at 2 years with injectable semaglutide in the SUSTAIN-6 trial
In line with this, the absorption of l-valine was also modest, supporting the theory that l-valine needs to be absorbed and metabolized to stimulate GLP-1 secretion
We understand that peptides can support hormone optimization, joint health, and metabolic balance when used responsibly
For patients with autoimmune thyroid disease, particularly Hashimoto's thyroiditis, there is no evidence that semaglutide adversely affects thyroid function or autoantibody levels